| Valarie Lynn Cataldi, RPH | |
|
47 Wintergreen Dr, Merrimack, NH 03054-3959 | |
| (603) 424-2540 | |
| Not Available |
| Full Name | Valarie Lynn Cataldi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 47 Wintergreen Dr, Merrimack, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366874133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1477 (New Hampshire) | Primary |
| 183500000X | Pharmacist | 6024 (Connecticut) | Secondary |
| 183500000X | Pharmacist | 19445 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Valarie Lynn Cataldi, RPH 47 Wintergreen Dr, Merrimack, NH 03054-3959 Ph: (603) 424-2540 | Valarie Lynn Cataldi, RPH 47 Wintergreen Dr, Merrimack, NH 03054-3959 Ph: (603) 424-2540 |
News Archive
Merge Healthcare, a leading health IT solutions provider, successfully deployed an imaging distribution solution for the physicians of UMass Memorial Health Care, an academic medical center with five facilities serving Central New England. iConnect Access™ gives physicians the ability to view medical images directly from their electronic health record.
When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company's Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.
Researchers from North Carolina State University have developed a wearable, wireless sensor that can monitor a person's skin hydration for use in applications that need to detect dehydration before it poses a health problem.
Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management.
› Verified 6 days ago
Gregory Vestal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519 | |
Stephen James Deminico, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-423-9330 Fax: 603-423-9336 | |
Lauren Herrick West, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519 | |
Renan Moretta, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4833 Fax: 603-424-4578 | |
Mr. Brad A Valenti, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Continental Blvd, Merrimack, NH 03054 Phone: 603-429-0759 Fax: 603-429-0813 | |
Dr. Meghan Armstrong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120 | |
Nancy Delaney, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120 |